home-glow

DDI Manager

Select the disease area and search for drug-drug interactions (DDI) between medications.

What’s new this week?

Preferred content

all topics

meeting-reports

lung cancer

Drug-drug interactions between antithrombotic agents and repotrectinib

David M. Burger

Read Article

podcasts

general

PODCAST: Flucloxacillin is a weak inducer of CYP3A4 by Dr. Iversen

Global DDI Solutions

Read Article

literature-updates

general

Drug-drug interactions with Over-the-Counter drugs

Global DDI Solution

Read Article

literature-updates

general

New method prediction renal drug-drug interactions in vivo related to renal OCT2/MATE1 transporters

Global DDI Solutions

Read Article

announcements

lung cancer

WEBINAR: Pharmacological Optimization of Lung Cancer Treatment Webinar

Global DDI Solutions

Read Article

announcements

lung cancer

New drug added to the Lung Cancer DDI Manager!

Global DDI Solutions

Read Article

meeting-reports

general

ESMO October 20-24, 2023; Madrid Spain

Global DDI Solutions

Read Article

meeting-reports

fungal infection

ID Week October 11-15, 2023; Boston USA

Global DDI Solutions

Read Article

meeting-reports

general

TIMM October 20-23, 2023

Global DDI Solutions

Read Article

articles

general

What the Product Label Does Not Tell You About Drug–Drug Interaction Management; Time for a Re-Appraisal

David M. Burger, Marianne le Comte, Elise J. Smolders, Tom G. Jacobs, Rob ter Heine, Catherijne A.J. Knibbe, and Munir Pirmohamed

Read Article

literature-updates

fungal infection

Utility of triazole antifungal therapeutic drug monitoring

Global DDI Solutions

Read Article

announcements

fungal infection

New drug rezafungin added!

Global DDI Solutions

Read Article

articles

fungal infection

Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs

Roger J Brüggemann, Rebecca Verheggen, Emmy Boerrigter, Marta Stanzani, Paul E Verweij, Nicole M A Blijlevens, Russell E Lewis

Read Article